After specialising in oncology she worked from 1992 to 1996 as a clinical research fellow at the Cancer Research Campaign's laboratories in Glasgow. From 1996-1998 she worked at Terry Fox Laboratory in Vancouver and discovered that primitive stem cells in CML existed in a quiescent state, and therefore they did not respond to cell cycle-active agents like imatinib.[5]